ResearcherYancheng Third People's HospitalActive in the last 2 years
Zhe Ding
Known by name at one institution; no external author ID yet. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2025: 2 papers
Papers 2
- Autophagy-targeted intervention synergized with pegaspargase: an innovative therapeutic paradigm for pancreatic cancer. First author DOI 10.1186/s12935-025-04074-5↗
- A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates alone or combined with autophagy inhibito… Last author DOI 10.3892/ijmm.2025.5507↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Xuyao Zhang · 2 shared papers, 2025 · strength 0.54
- Paper Autophagy-targeted intervention synergized with pegaspargase: an innovative therapeutic paradigm for pancreatic cancer. DOI 10.1186/s12935-025-04074-5↗
- Paper A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates a… DOI 10.3892/ijmm.2025.5507↗
- Chunbin Wang · 2 shared papers, 2025 · strength 0.54
- Paper Autophagy-targeted intervention synergized with pegaspargase: an innovative therapeutic paradigm for pancreatic cancer. DOI 10.1186/s12935-025-04074-5↗
- Paper A novel and promising therapeutic approach for treating pancreatic cancer: Nectin‑4‑targeted antibody‑drug conjugates a… DOI 10.3892/ijmm.2025.5507↗
- Dandan Zhou · 1 shared paper, 2025 · strength 0.28
- Rong Fu · 1 shared paper, 2025 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.